Jenburkt Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 355.08 million compared to INR 304.85 million a year ago. Revenue was INR 366.99 million compared to INR 315.07 million a year ago. Net income was INR 79.7 million compared to INR 56.72 million a year ago. Basic earnings per share from continuing operations was INR 17.37 compared to INR 12.36 a year ago.
For the six months, sales was INR 626.88 million compared to INR 479.16 million a year ago. Revenue was INR 650.74 million compared to INR 499.14 million a year ago. Net income was INR 126.21 million compared to INR 66.8 million a year ago. Basic earnings per share from continuing operations was INR 27.5 compared to INR 14.56 a year ago.